Ichthyosiform eruption and facial erythema secondary to ponatinib therapy

J Dtsch Dermatol Ges. 2020 Jul;18(7):743-747. doi: 10.1111/ddg.14154. Epub 2020 Jun 26.

Authors

Mónica Munera-Campos¹, Jose Manuel Carrascosa¹, Ariadna Quer², Carlos Ferrándiz¹

Affiliations

¹ Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain.
² Department of Pathology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain.

PMID: 32589336
DOI: 10.1111/ddg.14154

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Aged
Antineoplastic Agents / adverse effects*
Drug Eruptions / etiology*
Drug Eruptions / pathology
Erythema / chemically induced*
Female
Humans
Ichthyosis / chemically induced*
Ichthyosis / pathology
Imidazoles / adverse effects*
Male
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Pyridazines / adverse effects*

Substances

Antineoplastic Agents
Imidazoles
Pyridazines
ponatinib